|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on May 7, 2021. The analyst firm set a price target for 11.00 expecting VYNE to rise to within 12 months (a possible 206.41% upside). 1 analyst firms have reported ratings in the last year.
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.59 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for VYNE Therapeutics.
There is no upcoming split for VYNE Therapeutics.
VYNE Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.